Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 135.91 billion. The enterprise value is 185.24 billion.

Market Cap	135.91B
Enterprise Value	185.24B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Feb 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.16M

Valuation Ratios

The trailing PE ratio is 35.84.

PE Ratio	35.84
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.53, with an EV/FCF ratio of 32.88.

EV / Earnings	48.84
EV / Sales	5.93
EV / EBITDA	15.53
EV / EBIT	28.91
EV / FCF	32.88

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 8.02.

Current Ratio	1.32
Quick Ratio	0.80
Debt / Equity	8.02
Debt / EBITDA	4.86
Debt / FCF	9.61
Interest Coverage	2.07

Financial Efficiency

Return on equity (ROE) is 55.72% and return on invested capital (ROIC) is 6.13%.

Return on Equity (ROE)	55.72%
Return on Assets (ROA)	4.60%
Return on Capital (ROIC)	6.13%
Revenue Per Employee	1.09M
Profits Per Employee	142,046
Employee Count	26,700
Asset Turnover	0.36
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.53% in the last 52 weeks. The beta is 0.60, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-2.53%
50-Day Moving Average	278.49
200-Day Moving Average	282.41
Relative Strength Index (RSI)	41.18
Average Volume (20 Days)	1,072

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.46

Income Statement

In the last 12 months, Amgen had revenue of EUR 29.17 billion and earned 3.79 billion in profits. Earnings per share was 7.02.

Revenue	29.17B
Gross Profit	17.67B
Operating Income	5.98B
Pretax Income	4.20B
Net Income	3.79B
EBITDA	10.98B
EBIT	5.98B
Earnings Per Share (EPS)	7.02

Full Income Statement

Balance Sheet

The company has 8.08 billion in cash and 54.15 billion in debt, giving a net cash position of -46.07 billion.

Cash & Cash Equivalents	8.08B
Total Debt	54.15B
Net Cash	-46.07B
Net Cash Per Share	n/a
Equity (Book Value)	6.75B
Book Value Per Share	12.56
Working Capital	5.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.51 billion and capital expenditures -873.29 million, giving a free cash flow of 5.63 billion.

Operating Cash Flow	6.51B
Capital Expenditures	-873.29M
Free Cash Flow	5.63B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.59%, with operating and profit margins of 20.51% and 13.00%.

Gross Margin	60.59%
Operating Margin	20.51%
Pretax Margin	14.38%
Profit Margin	13.00%
EBITDA Margin	37.64%
EBIT Margin	20.51%
FCF Margin	19.31%

Dividends & Yields

This stock pays an annual dividend of 8.35, which amounts to a dividend yield of 3.36%.

Dividend Per Share	8.35
Dividend Yield	3.36%
Dividend Growth (YoY)	6.20%
Years of Dividend Growth	11
Payout Ratio	112.70%
Buyback Yield	-0.42%
Shareholder Yield	2.94%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on November 22, 1999. It was a forward split with a ratio of 2.

Last Split Date	Nov 22, 1999
Split Type	Forward
Split Ratio	2

Scores

Amgen has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	n/a